Press Release | January 4, 2023
Immunitas Therapeutics Announces First Patient Dosed in Phase 1/2a Study of IMT-009
Read More
News | January 3, 2023
Viewpoint: Expanding TRIPS waiver is bad for innovation
Read More
News | December 15, 2022
Metagenomi Announces Publication of Data in Nature Communications Describing Novel, Ultra-Small Nucleases for Gene Editing
Read More
Press Release | December 15, 2022
Pliant Therapeutics Receives Orphan Designation from the European Medicines Agency for Bexotegrast (PLN-74809) for the Treatment of Idiopathic Pulmonary Fibrosis
Read More
